These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16629557

  • 1. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide.
    Hugel H, Ellershaw J, Gambles M.
    J Palliat Med; 2006 Apr; 9(2):279-84. PubMed ID: 16629557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hyoscine vs glycopyrronium for drying respiratory secretions in dying patients.
    Lawrey H.
    Br J Community Nurs; 2005 Sep; 10(9):421-4, 426. PubMed ID: 16234752
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion.
    Lindqvist O, Lundquist G, Dickman A, Bükki J, Lunder U, Hagelin CL, Rasmussen BH, Sauter S, Tishelman C, Fürst CJ, OPCARE9.
    J Palliat Med; 2013 Jan; 16(1):38-43. PubMed ID: 23234300
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Respiratory tract secretions in the dying patient: a retrospective study.
    Kåss RM, Ellershaw J.
    J Pain Symptom Manage; 2003 Oct; 26(4):897-902. PubMed ID: 14527758
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New potential uses for transdermal scopolamine (hyoscine).
    La Rovere MT, De Ferrari GM.
    Drugs; 1995 Nov; 50(5):769-76. PubMed ID: 8586025
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pilot phase II randomized, cross-over, double-blinded, controlled efficacy study of octreotide versus hyoscine hydrobromide for control of noisy breathing at the end-of-life.
    Clark K, Currow DC, Agar M, Fazekas BS, Abernethy AP.
    J Pain Palliat Care Pharmacother; 2008 Nov; 22(2):131-8. PubMed ID: 19042837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Reducing loud respiratory sounds of dying patients].
    Ivanovic N, Fringer A.
    Pflege Z; 2014 Oct; 67(10):612-3. PubMed ID: 25522470
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.